The chart below shows how IONQ performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IONQ sees a -0.79% change in stock price 10 days leading up to the earnings, and a +2.11% change 10 days following the report. On the earnings day itself, the stock moves by -0.91%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Record Bookings Growth: 2024 was IonQ's best year ever, with full-year bookings growing by 47% to $95.6 million.
Revenue Surges Exceeding Expectations: Revenue nearly doubled, achieving $43.1 million for the year and $11.7 million for the fourth quarter, both exceeding guidance.
Quantum Networking Enhancement: IonQ acquired Qubitekk, enhancing its capabilities in quantum networking and distributed quantum computing.
Strategic Acquisition Announcement: IonQ signed a definitive agreement to acquire a controlling stake in ID Quantique, consolidating a significant portfolio of patents and business.
Product Launch Success: The company delivered its first Forte enterprise system to QuantumBasel and the Air Force Research Lab, showcasing its product capabilities.
Strategic Partnerships Progressing: IonQ's collaboration with AstraZeneca on drug discovery and with Ansys on computer-aided engineering is progressing well, indicating strong partnerships.
Technical Progress Milestone: The company is on track to achieve AQ 64 by the end of the year, demonstrating significant technical progress.
Leadership Transition and Growth: Leadership changes, including the appointment of Niccolo de Masi as CEO, are expected to drive growth and strategic direction.
Quantum Networking Investment: IonQ launched a $500 million at-the-market facility to support its growth in quantum networking and applications.
2025 Revenue Guidance: Revenue guidance for 2025 is projected between $75 million to $95 million, indicating continued growth momentum.
Negative
Increased Net Loss: Net loss of $202 million in Q4 2024, compared to $41.9 million in the prior year period, indicating a significant increase in losses.
Net Loss Increase: Full-year net loss of $331.6 million for 2024 versus $157.8 million in 2023, showing a worsening financial situation year-over-year.
Rising Operational Costs: Total operating costs and expenses were $89.2 million in Q4 2024, up 47% from $60.6 million in the prior year period, indicating rising operational costs.
Rising Administrative Costs: General and administrative costs in Q4 were $29.7 million, up 94% from $15.3 million in the prior year period, reflecting unsustainable growth in overhead expenses.
Stock-Based Compensation Increase: Stock-based compensation increased to $106.9 million for the full-year 2024, up from $69.7 million in 2023, which could indicate potential issues with employee retention or compensation strategy.
Deteriorating Operational Efficiency: Adjusted EBITDA loss for Q4 was $32.8 million, compared to a $20 million loss in the prior year period, indicating deteriorating operational efficiency.
Projected EBITDA Loss: Projected adjusted EBITDA loss of $120 million for the full-year 2025 at the midpoint of revenue guidance, suggesting continued financial strain ahead.
IonQ, Inc. (IONQ) Q4 2024 Earnings Call Transcript
IONQ.N
5.07%